Connection
Benjamin Bitler to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Benjamin Bitler has written about Antineoplastic Agents, Hormonal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.052 |
|
|
|
-
Shao C, Indeglia A, Foster M, Casey K, Leung J, Modarai SR, Leu JI, Duong B, Mes-Masson AM, Sims-Mourtada J, Auslander N, Drapkin R, Bitler BG, Zhang N, Murphy ME. Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. Genes Dev. 2026 02 02; 40(3-4):199-214.
Score: 0.052